NCT06239272 2026-01-26NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)St. Jude Children's Research HospitalPhase 1/2 Recruiting139 enrolled
NCT04094610 2025-11-19A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 AlterationsTurning Point Therapeutics, Inc.Phase 1/2 Recruiting75 enrolled
NCT07118176 2025-08-12Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersJonsson Comprehensive Cancer CenterPhase 1 Recruiting30 enrolled
NCT03277924 2024-08-13ImmunoSarcGrupo Espanol de Investigacion en SarcomasPhase 1/2 Completed197 enrolled